Philip W. Kantoff
CIK: 0001866025
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CNTX
Context Therapeutics Inc.
Director
Discretionary Trading P&L
Holdings
About Kantoff Philip W.
Kantoff Philip W. (SEC CIK 0001866025) files insider reports with the SEC as Director of Context Therapeutics Inc. (CNTX).
Signal8 holds 2 ownership filings by Kantoff Philip W., all Form 4s, filed between Jun 12, 2025 and Jun 26, 2026. Those filings report 2 transactions, from Jun 12, 2025 to Jun 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Kantoff Philip W.'s filings is in PHILADELPHIA, PA.
Recent filings by Kantoff Philip W.
Other insiders filing for Context Therapeutics Inc. (CNTX)
- Pasternak Andy, Director
- Stacey Jennifer Evans, Director
- West Linda, Director
- Smith Karen L., Director
- Walker Luke Nathaniel, Director
- Levit Alex C., Chief Legal Officer, Corp. Sec